Therapy Areas: Oncology
Vial adds new member to company's Advisory Board
28 November 2022 -

Vial, a US-based, tech-enabled CRO providing next-generation clinical trial management services, announced on Sunday that it has added Marc Hoffmann, MD to the company's Advisory Board.

In the new role, Dr Hoffmann will work closely with the firm's leadership team to shape the scientific strategy of its Oncology CRO products and services.

Dr Hoffman is the medical director for Lean and Quality Improvement in the Cancer Center, Chair of the Lymphoma/Myeloma Disease Working Group, and an associate professor at the University of Kansas.

Login
Username:

Password: